These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2036708)

  • 1. Phorbol dibutyrate stimulates the release of diffusible endothelium-derived vasoconstrictor factor(s) from canine femoral arteries.
    Rubanyi GM; Luisi A; Johns A
    Circ Res; 1991 Jun; 68(6):1527-31. PubMed ID: 2036708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels.
    Rubanyi GM; Desiderio D; Luisi A; Johns A; Sybertz EJ
    J Pharmacol Exp Ther; 1989 Jun; 249(3):858-63. PubMed ID: 2499677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium-induced release of endothelium-derived relaxing factor from canine femoral arteries.
    Rubanyi GM; Vanhoutte PM
    Circ Res; 1988 Jun; 62(6):1098-103. PubMed ID: 3260148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-dependent pressure-induced contraction of isolated canine carotid arteries.
    Rubanyi GM
    Am J Physiol; 1988 Oct; 255(4 Pt 2):H783-8. PubMed ID: 3177669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine arteries release two different endothelium-derived relaxing factors.
    Hoeffner U; Feletou M; Flavahan NA; Vanhoutte PM
    Am J Physiol; 1989 Jul; 257(1 Pt 2):H330-3. PubMed ID: 2787604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of endothelium-dependent responses to acetylcholine in canine femoral arteries and veins. Separation of the role played by endothelial and smooth muscle cells.
    Rubanyi GM; Vanhoutte PM
    Blood Vessels; 1988; 25(2):75-81. PubMed ID: 3257889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterization of muscarinic receptors.
    Rubanyi GM; McKinney M; Vanhoutte PM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):802-8. PubMed ID: 2435886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective effect of diltiazem on endothelium-dependent relaxations in canine femoral arteries.
    Rubanyi GM; Hoeffner U; Schwartz A; Vanhoutte PM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):60-4. PubMed ID: 2455796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular actions of TA 3090, a novel analog of diltiazem: interaction with endothelium-dependent relaxation in canine femoral and coronary arteries.
    Rubanyi G; Iqbal A; Schwartz A; Vanhoutte PM
    J Pharmacol Exp Ther; 1991 Nov; 259(2):639-42. PubMed ID: 1941612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of protein kinase C in endothelin-induced contractions in rat aortic rings.
    Oriji GK; Keiser HR
    Am J Physiol; 1996 Jul; 271(1 Pt 1):C398-404. PubMed ID: 8760071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phorbol esters on canine coronary artery constriction and dilation in vitro.
    Sheridan FM; Horwitz LD; McMurtry IF
    Am J Physiol; 1991 Jul; 261(1 Pt 2):H236-42. PubMed ID: 1858925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C and vascular smooth muscle contractility: effects of inhibitors and down-regulation.
    Merkel LA; Rivera LM; Colussi DJ; Perrone MH
    J Pharmacol Exp Ther; 1991 Apr; 257(1):134-40. PubMed ID: 2019982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propofol inhibits phorbol 12, 13-dibutyrate-induced, protein kinase C-mediated contraction of rat aortic smooth muscle.
    Yu J; Kakutani T; Mizumoto K; Hasegawa A; Hatano Y
    Acta Anaesthesiol Scand; 2006 Oct; 50(9):1131-8. PubMed ID: 16987344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-derived relaxing factor released from canine femoral artery by acetylcholine cannot be identified as free nitric oxide by electron paramagnetic resonance spectroscopy.
    Greenberg SS; Wilcox DE; Rubanyi GM
    Circ Res; 1990 Dec; 67(6):1446-52. PubMed ID: 2173981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium-free solution prevents the action but not the release of endothelium-derived relaxing factor.
    Rubanyi GM; Vanhoutte PM
    Eur J Pharmacol; 1988 Jan; 145(3):351-5. PubMed ID: 3258243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
    Blaise GA; Stewart DJ; Guérard MJ
    Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium.
    Rubanyi GM; Vanhoutte PM
    J Physiol; 1985 Jul; 364():45-56. PubMed ID: 3861856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Chloroadenosine prevents phorbol ester-induced depletion of protein kinase C in porcine coronary artery.
    Marala RB; Ways K; Mustafa SJ
    Am J Physiol; 1993 May; 264(5 Pt 2):H1465-71. PubMed ID: 8498561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow.
    Miller VM; Vanhoutte PM
    Am J Physiol; 1988 Sep; 255(3 Pt 2):H446-51. PubMed ID: 3137826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral vascular smooth muscle responsiveness to tumour-promoting phorbol esters in pacing-induced heart failure.
    Forster C
    Can J Physiol Pharmacol; 1995 May; 73(5):651-60. PubMed ID: 7585333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.